Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Status:
Completed
Trial end date:
2020-06-12
Target enrollment:
Participant gender:
Summary
This study evaluates the use of ABI-1968, a topical cream, in the treatment of cervical
precancerous lesions in females without human immunodeficiency virus (HIV) infection.